Skip to content
Original data·Apr 21, 2026·9 min read

How to measure CAC by procedure for cosmetic clinics

Most clinics roll CAC up. We split it. Here's the cohort math that surfaces which procedures actually fund the chair.

P
PYKSL Editorial
Analytics
How to measure CAC by procedure for cosmetic clinics
TL;DR
  • 01

    A single blended CAC hides which procedures actually pay. Split acquisition cost by procedure and the picture usually inverts — the cheapest patient to acquire is often the least profitable, while a "high CAC" procedure quietly funds the clinic.

  • 02

    The method is simple cohort math: attribute spend and bookings to the procedure that brought the patient in, then track first-treatment value and payback per cohort. You need roughly three months of clean tracking to trust it.

  • 03

    Across our cosmetic cohort the spread was wide — injectables acquired cheaply but on thin first-visit value, while device and body work cost more up front and paid back faster. Your clinic will differ; the point is to measure it, not borrow ours.

Why a single blended CAC lies

Most clinics track one acquisition cost across the whole business. It feels tidy and it's almost useless. A clinic can post a healthy blended CAC while quietly overspending to acquire low-value patients and underspending on the procedures that pay the lease.

The average is a number you can report but can't act on. The split is what tells you where to move the next dirham — and it usually contradicts the gut feel about which campaigns are "working".

The cohort method: splitting CAC by procedure

For each new patient, attribute the campaign spend and the booked consult to the procedure named in the enquiry. Then follow that cohort: first-treatment value, whether they rebook, and how long the cash takes to come back. Blended CAC for the cohort is simply qualifying spend divided by first-time patients in it.

It isn't exotic analytics — it's disciplined attribution plus patience. The hard part is clean tracking at the point of enquiry, which is exactly what most clinic funnels lose.

What we see across the cohort

The table below is indexed to the lowest-CAC cohort rather than quoted in currency — because absolute CAC swings hard by market, season and offer, and a dollar figure would imply a precision we don't have. The shape travels between clinics; the magnitude does not.

Procedure cohortBlended CAC (indexed)Booked-consult rateFirst-treatment valuePayback profile
Injectables (tox / filler)1.0× (lowest)HighLow–mediumSlow on first visit, fast on repeat
Memberships / skincare1.2×HighRecurringCompounds — best LTV:CAC over 12 months
Laser & skin (devices)1.6×MediumMedium–highFaster — higher first ticket
Body contouring2.3×LowerHighFast per patient, lower volume
Surgical / consult-led2.8× (highest)LowVery highLong cycle, high value
Illustrative CAC by procedure — PYKSL cosmetic cohort (n=8 clinics, GCC & UK, 2025). Directional, not a public benchmark.

What to do with the split

Once you can see it, the moves are obvious. Stop judging injectable campaigns on first-visit value — judge them on 12-month repeat, where memberships and skincare quietly win. Give device and body work the budget their payback justifies even though the CAC headline looks scary. And put your best creative and fastest follow-up on the consult-led procedures, where one booked patient covers a lot of cheap clicks.

The split changes the question from "which campaign has the lowest CAC" to "which procedure funds the chair" — and those are rarely the same answer.

Methodology and caveats

Method: for each new patient we attribute qualifying campaign spend and the booked consult to the procedure named in the enquiry, then track that cohort's first-treatment value and repeat behaviour for 12 months. Blended CAC = qualifying spend ÷ first-time patients in the cohort.

Caveats: a single cohort of eight clinics across the GCC and UK, 2025. Figures are indexed, not currency, and deliberately so. This is directional, not a public benchmark and not a substitute for your own numbers — run the same split on your account before you reallocate a dirham. The only CAC that matters is yours.

Questions we get
  • 01

    What is CAC by procedure?

    It is customer-acquisition cost calculated per procedure cohort rather than across the whole clinic. You attribute spend and bookings to the procedure that brought each patient in, so you can see which services actually fund the chair instead of one blended average.

  • 02

    Why not just use blended CAC?

    Because it averages away the signal. A clinic can show a healthy blended CAC while overspending on low-value patients and underspending on the procedures that pay. The split tells you where to move budget; the average tells you nothing actionable.

  • 03

    How much data do I need before the split is reliable?

    Roughly three months of clean, tracked bookings per procedure — enough cohort volume that one or two outlier patients do not swing the number. Less than that and you are reading noise.

  • 04

    Do your benchmark numbers apply to my clinic?

    Treat them as directional only. They are indexed from a single eight-clinic cohort and the magnitudes will not transfer to your market. The method transfers; the numbers do not. Run the split on your own account.

If this was useful

Want it applied to your business?

30 minutes. We review your acquisition data, ad accounts and unit economics. You leave with a thesis, whether you engage us or not.